Collaboration will leverage Unlearn's AI-powered digital twins in QurAlis' clinical trials for their leading ALS therapies CAMBRIDGE, Mass. and SAN FRANCISCO, June 27, 2023 /PRNewswire/ -- QurAlis ...
SAN FRANCISCO--(BUSINESS WIRE)--In 2024, Unlearn ® achieved key milestones in advancing AI to eliminate trial and error in medicine. From securing $50M in Series C ...
Unlearn, an AI-enabled company creating digital twins of clinical trial participants, announced a partnership to advance ALS research with biotechnology company Trace Neuroscience, which creates ...
Unlearn experts outline current reality of AI-powered digital twins and the steps needed to actualize the technology’s potential in clinical practice The manuscript explores the transformative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback